🔎 Trials Near Me

Gara Jalqabaatti › Melanoma › Virginia › Arlington

Qorannoo klinikaalii Melanoma Arlington, VA keessatti

Qorannoo 20 Melanoma f Arlington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
  • NEXT Virginia, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06270706

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Namoota walitti qabaa jiraSadarkaa 2
  • Inova Schar Cancer Institute ( Site 4046), Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06961006

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Inova Schar Cancer Infusion Pharmacy, Fairfax · Miili 11 fagaatti
  • Inova Schar Cancer, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07519655

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Namoota walitti qabaa jiraSadarkaa 3
  • Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06246916

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Namoota walitti qabaa jiraSadarkaa 2
  • Inova Fairfax Hospital, Falls Church · Miili 4 fagaatti
  • Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
  • Inova Fair Oaks Hospital, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05136196

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Virginia Cancer Specialists-Fairfax, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07287917

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT04913285

Project: Every Child for Younger Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Inova Fairfax Hospital, Falls Church · Miili 4 fagaatti
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07115043

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Clinical Trial Site, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06330064

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Namoota walitti qabaa jiraSadarkaa 1/2
  • Next Oncology Virginia, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Cam-2026 · NCT05379985

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology - Virginia, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Elb-2026 · NCT06326411

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Virginia, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07317505

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

Namoota walitti qabaa jiraSadarkaa 1
  • NEXT Oncology, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Sad-2025 · NCT06332755

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site 102, Fairfax · Miili 11 fagaatti
  • Research Site 112, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Sad-2025 · NCT05914116

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Onk-2025 · NCT04370587

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2025 · NCT05669430

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Namoota walitti qabaa jiraSadarkaa 1/2
  • NEXT Virginia, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ama-2025 · NCT06090266

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Next Oncology, Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Ama-2024 · NCT05746897

Qorannoo Melanoma magaalota biroo keessatti

Qorannoo biroo Arlington keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.